感觉性多神经病的诊断与治疗
感觉性多神经病由外周感觉神经纤维功能障碍引起,涵盖从常见糖尿病神经病变到罕见感觉神经元病的异质性疾病群。诊断评估包括神经传导研究等电生理检查、神经组织病理分析、血清学检查,有时需自主神经测试和脑脊液分析。治疗取决于病因,可能包括免疫治疗、危险因素控制、对症治疗和基因治疗。
要点
- 小纤维受损导致神经病理性疼痛,大纤维受损导致本体感觉缺失和共济失调。
- 特发性感觉性多神经病常见,但应视为排除性诊断。
- 许多感觉性多神经病无针对性治疗,处理以对症和支持为主。
核心结论
- 感觉性多神经病是一组异质性疾病,诊断需结合电生理、病理和血清学检查,治疗取决于病因,许多疾病无针对性治疗。
研究设计与样本
- 综述,未报告系统检索范围。
主要发现
- 小纤维受损导致神经病理性疼痛,大纤维受损导致本体感觉缺失和共济失调。
- 病因包括代谢性、中毒性、感染性、炎症性、自身免疫性和遗传性。
- 特发性感觉性多神经病常见,但应视为排除性诊断。
- 诊断评估包括神经传导研究、神经组织病理分析、血清学检查,有时需自主神经测试和脑脊液分析。
- 治疗包括免疫治疗、危险因素控制、对症治疗和基因治疗,如针对转甲状腺素蛋白家族性淀粉样多神经病的RNA干扰和反义寡核苷酸疗法。
临床怎么用
- 诊断评估包括电生理测试(如神经传导研究)、神经组织病理分析、血清学检查,有时需自主神经测试和脑脊液分析。
- 治疗取决于病因,可能包括免疫治疗、危险因素控制、对症治疗和基因治疗。
- 许多感觉性多神经病无针对性治疗,处理以对症和支持为主。
- 作者指出需要更多研究来阐明神经损伤的病理生理机制,以指导治疗进展。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sensory polyneuropathies, which are caused by dysfunction of peripheral sensory nerve fibers, are a heterogeneous group of disorders that range from the common diabetic neuropathy to the rare sensory neuronopathies. The presenting symptoms, acuity, time course, severity, and subsequent morbidity vary and depend on the type of fiber that is affected and the underlying cause. Damage to small thinly myelinated and unmyelinated nerve fibers results in neuropathic pain, whereas damage to large myelinated sensory afferents results in proprioceptive deficits and ataxia. The causes of these disorders are diverse and include metabolic, toxic, infectious, inflammatory, autoimmune, and genetic conditions. Idiopathic sensory polyneuropathies are common although they should be considered a diagnosis of exclusion. The diagnostic evaluation involves electrophysiologic testing including nerve conduction studies, histopathologic analysis of nerve tissue, serum studies, and sometimes autonomic testing and cerebrospinal fluid analysis. The treatment of these diseases depends on the underlying cause and may include immunotherapy, mitigation of risk factors, symptomatic treatment, and gene therapy, such as the recently developed RNA interference and antisense oligonucleotide therapies for transthyretin familial amyloid polyneuropathy. Many of these disorders have no directed treatment, in which case management remains symptomatic and supportive. More research is needed into the underlying pathophysiology of nerve damage in these polyneuropathies to guide advances in treatment.
引用
- Gwathmey KG, Pearson KT. Diagnosis and management of sensory polyneuropathy. BMJ. 2019. PMID: 31068323. doi:10.1136/bmj.l1108
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。